Payer Perspectives in Dermatology

Payers' Perspectives

Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea

Lisa A. Raedler, PhD, RPh

Combating Antibiotic Resistance a National Priority Reinforced by a New Executive Order

The Impact of Rosacea and Acne on a Patient’s Quality of Life Is Comparable to Other Chronic Conditions

Novel Rosacea Compound, Ivermectin Cream, Offers Unique Mechanism of Action

Caroline Helwick

Ivermectin Cream Will Contribute Much to the Treatment of Patients with Rosacea: Interview with Dr Zoe Draelos

Caroline Helwick

Addressing an Unmet Need in the Treatment of Patients with Papulopustular Rosacea: An Interview with Dr Linda Stein Gold

Caroline Helwick

Investigational Agent Clears Papulopustular Rosacea by Tackling an Underlying Cause

Caroline Helwick

The Social Impact of Rosacea, Patterns of Care, and Associated Costs Featured at AAD 2014

Caroline Helwick

AAD 2014 Highlights: Understanding Inflammation Markers and Treating Erythema in Rosacea

Caroline Helwick

Rosacea: A Multifaceted Skin Disorder

Caroline Helwick

1
2
3

Page 1 of 3
Results 1 - 10 of 25

SUBSCRIBE

© Amplity Health. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.